I think that the key is May 14th: Meaning that Titan expects something to close before that date and get some serious $$$, could be either: - Probuphine rights been sold again - Agreement to pre-licence Ropirinole - Molteni paying for the remainder of their sales agreement + a few other countries in EU (1MM$ per extra country) - Malaria application being licensed..
Those are my candidates for May 14th ... I do not foresee further dilution at this price level..